CH452513A - Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden - Google Patents

Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden

Info

Publication number
CH452513A
CH452513A CH5764A CH5764A CH452513A CH 452513 A CH452513 A CH 452513A CH 5764 A CH5764 A CH 5764A CH 5764 A CH5764 A CH 5764A CH 452513 A CH452513 A CH 452513A
Authority
CH
Switzerland
Prior art keywords
bisdehydrosteroids
preparation
Prior art date
Application number
CH5764A
Other languages
English (en)
Inventor
Tanabe Masato
L Shapiro Elliot
P Oliveto Eugene
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US251744A external-priority patent/US3127428A/en
Priority claimed from US263441A external-priority patent/US3332967A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of CH452513A publication Critical patent/CH452513A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card games appurtenances
    • A63F1/18—Score computers; Miscellaneous indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
CH5764A 1963-01-16 1964-01-07 Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden CH452513A (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture
US31227363A 1963-09-30 1963-09-30

Publications (1)

Publication Number Publication Date
CH452513A true CH452513A (de) 1968-03-15

Family

ID=27500405

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5764A CH452513A (de) 1963-01-16 1964-01-07 Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden

Country Status (4)

Country Link
CH (1) CH452513A (de)
DE (1) DE1493146A1 (de)
DK (1) DK114971B (de)
SE (1) SE314366B (de)

Also Published As

Publication number Publication date
DK114971B (da) 1969-08-25
DE1493146A1 (de) 1969-08-07
SE314366B (de) 1969-09-08

Similar Documents

Publication Publication Date Title
CH468966A (de) Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH437316A (de) Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH436317A (de) Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
AT247866B (de) Verfahren zur Herstellung von 2, 6-Dichlorbenzonitril
CH446312A (de) Verfahren zur Herstellung von cis,cis-Cyclodecadien-(1,6)
CH437320A (de) Verfahren zur Herstellung von 4-Amino-5-hydroxypyridazonen (6)
CH451163A (de) Verfahren zur Herstellung von 2,2-Bipyridylium-dihalogeniden
CH445477A (de) Verfahren zur Herstellung von 1-Hydroxy-2,2,6,6-tetrachlorcyclohexankarbonamid-1
CH441352A (de) Verfahren zur Herstellung von 1-Phenyl-3-butyl-4-methyl-triazolon-(5)
CH459242A (de) Verfahren zur Herstellung von 1,2-Dihydro-1-hydroxy-1,3,5-triazinen
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH435245A (de) Verfahren zur Herstellung von 1-Aryl-perchlor-2-aza-alkenen-(2)
CH427830A (de) Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen
CH444154A (de) Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten
AT240356B (de) Verfahren zur Herstellung von neuen 1, 2-Diaryl-4-alkyl-3, 5-dioxo-pyrazolidinen
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen